Skip to main content
. 2023 Jan 12;48(6):929–935. doi: 10.1038/s41386-022-01527-7

Table 1.

Baseline characteristics of study participants by treatment group.

Placebo (n = 10) EPA 1 g/d (n = 13) EPA 2 g/d (n = 11) EPA 4 g/d (n = 11)
Men/women (n) 2/8 4/9 3/8 4/7
Age (y) 52 ± 13 41 ± 16 47 ± 15 43 ± 15
BMI (kg/m2) 38.8 (9.6) 33.0 (6.7) 34.3 (7.7) 35.7 (8.8)
Hs-CRP (µg/mL) 6.9 (4.5) 3.6 (8.3) 4.8 (1.2) 3.9 (4.7)
IDS-C30 36.6 ± 10.5 36.1 ± 7.4 31.4 ± 7.1 31.5 ± 5.0

Data presented as mean ± SD or median (IQR).